chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1pm on 06/11/2021 I experienced stroke symptoms. was rushed by ambulance to Hospital. CAT scan, MRI were done and TPA was given. No large blood clots were found but meds were used as precaution for smaller clots. Was transferred to Hospital to  Neurological Stroke Unit ICU was there for 4 days. I was tested for various viruses and shingles they were negative including the Covid test. They found a problem with 7th nerve bundle . Bell"s Palsy was diagnosed .  They are researching how and why this occurred. I am home resting and recuperating.
I had injection site pain through the remainder of the vaccine day and for a few days following. I woke up around 3 or 3:30 am the following day with a fever, chills, nausea and body aches. Throughout the day I alternated between chills and sweating. I took Tylenol to reduce the fever, and the Tylenol and Zofran (taken daily for unrelated treatment) helped with the nausea. I also had body aches and fatigue. I do not believe the nausea led to vomiting though it was close. These symptoms were largely gone by the following day (Saturday, 3/13/21).  For a few days the injection arm was painful and heavy to lift. The armpit on that side was also swollen. These lasted until around Sunday or Monday (3/14 or 3/15)
On the 9th day after vaccination injection site became itchy, hive like, inflamed, hard and swollen.
mom reports that pt devel a fever of 102-103 that was controlled w/APAP;had lethargy, vomiting & cried x 2-3 hr;saw MD 11JUL96 & morning of 12JUL96;
About 24 hours after vaccine , an itching /burning rash started on the side of my face. it spread from chin area up to high cheekbone area. It was red but not bumpy, hardly visible. The Itching continued and has not subsided since it started. That side of my face appeared swollen. My lips were also itching.My throat on the same side as rash feels itchy as well. I began taking  Benadryl every 6 hours with only slight improvement. I still have a rash after four days. The rash has not spread and remains in the same area. 4 days.
Information has been received from a physician concerning a patient (age and gender not reported) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient experienced an injection site reaction. The patient's sought unspecified medical attention. The patient's status was reported as "improved after a couple of days". There was no product quality complaint involved. Attempts are being made to obtain additional identifying information to distinguish the individual patient mentioned in this report. Additional information will be provided if available. This is one of several reports received from the same source. Additional information has been requested.
Body Pain; Chills; Elevated temperature; severe flu like symptoms; fever; This non-serious case was reported by a consumer via call center representative and described the occurrence of general body pain in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 09-MAR-2023, the patient received the 1st dose of Shingrix. In MAR-2023, 24 hrs after receiving Shingrix, the patient experienced general body pain (Verbatim: Body Pain), chills (Verbatim: Chills), body temperature increased (Verbatim: Elevated temperature), influenza-like symptoms (Verbatim: severe flu like symptoms) and fever (Verbatim: fever). In MAR-2023, the outcome of the general body pain, chills, body temperature increased, influenza-like symptoms and fever were resolved (duration 48 hrs).   It was unknown if the reporter considered the general body pain, chills, body temperature increased, influenza-like symptoms and fever to be related to Shingrix.   It was unknown if the company considered the general body pain, chills, body temperature increased, influenza-like symptoms and fever to be related to Shingrix.   Additional Information: GSK Receipt Date:20-JUN-2023. The reporter stated that the patient reported having severe flu like symptoms after 1st dose of Shingrix vaccine. The patient also reported having fever or elevated temperature, chills and body pain. The patient had fever or elevated temperature since he did not use a thermometer. The symptoms resolved and recovered within 48 hours . It was not confirmed weather the patient had taken the second dose of vaccination or not. The reporter consented to follow up.
Information has been received from a nurse practitioner concerning a female who was vaccinated with the first dose of GARDASIL IM. The patient got her first dose of GARDASIL vaccine and got "sxs". The patient experienced depression, fainting and fatigue. The father of the patient would like guidance on what to do especially whether the second and third dose should be administered. The patient sought unspecified medical attention. Follow up information concerning a 16 year old female patient with headache at the time of vaccination and no known drug allergies who on 04-SEP-2008 at 12:00 pm was vaccinated with the first dose of GARDASIL (lot # 660555/0279X). On 08-JAN-2009 the patient passed out (first syncope episode). On 27-APR-2009 cardiac echocardiogram was performed (results not provided). On 15-MAY-2009 Exercise Tolerance test (ETT) was performed (result not provided). On 20-MAY-2009 the patient consulted neurology. Outcome of passed out was unknown at the time of reporting. No further information is available.
Swelling, pain and weakness of left wrist and hand.  I have had this to date since  adverse reactions started.
Pt recvd vax 14AUg92 & following vax exp bad taste in mouth & bad, stale smell;
Eczema cleared up by 90 percent.; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Eczema cleared up by 90 percent.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A, 032B21A and 939906) for COVID-19 vaccination.     Concurrent medical conditions included Eczema (Severe eczema on her scalp, neck, eye brows and facial cheeks.).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Eczema cleared up by 90 percent.). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Eczema cleared up by 90 percent.) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was unknown.  Patient stated that she was unsure if the improvement started after the first or second vaccine.
On 12/25/2000 the patient experienced blisters, fever, cough, runny nose and congestion. On 12/28/2000 the patient was seen in her physician's office for varicella. In follow up, the physician reported that the patient developed chicken pox on 12/28/2000, and described the appearance as an "attenuative form of pox". The patient was treated with cephalexin and acyclovir. The patient recovered. No further information is expected.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age. Information regarding relevant medical history and concurrent condition were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX (0.65 ml, subcutaneous, lot # not reported) to prevent shingles. Information regarding concomitant medications was not reported. "Two days after" receiving ZOSTAVAX (date unspecified), the patient developed cellulitis (unspecified location on body). The patient was seen by an unspecified physician (unspecified date) and was prescribed a "low dose" unspecified antibiotic. No lab diagnostics studies were performed. The outcome of cellulitis was unknown. Additional information has been requested.
Rash for 3 days, raised hard red bump on site for a week, site scarred (still visible to this day)
Patient has relapsing / remitting multiple sclerosis and has had several exacerbations in past 2 years.  Had flu vaccine and tetanus at another facility approx 4 days prior to pneumovax at our facility.  The following day he began to have new right hemiparesis and worsening of diplopia that had previously been improving. NOTE:  MULTIPLE VACCINATIONS ON TWO DIFFERENT DAYS!!! This happened just last week.
STARTED HAVING AXILLARY PAIN NEXT DAY AND FELT SOME NODE SWELLING BUT IT SLOWLY WENT AWAY. THEN I HAD THE SECOND DOSE IN THE SAME ARM AND STARTED PAIN ANS SOME SWELLING BACK TO THE SAME LEFT AXILLA.I HAD BODY ACHES AND TIRED NESS THE NEXT DAY, I TOOK TYLENOL ES 2 TABS.
Patient's husband called DPH to report his wife has had elevated BP and "tingling in her head" since receiving the Tdap 3 days prior on 5/31/16. She had not eaten lunch but had eaten 5 hrs. prior to vaccination. He reports her normal BP is 116/70 HR in 70s which is taken by home digital automatic cuff but after she went to eat after vaccination and upon returning home her BP was 136/96 HR 90s. Husband reports she is feeling better that BP normal and tingling in head better. She layed down and took nap because felt weak and had headache. She did not take any NSAIDs for discomfort. Symptoms gradually improved. Husband reports she took BP.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2022 at 5:40 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-MAR-2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The patient had received the vaccine dose number booster. No concomitant medications were reported. It was reported that a series of an approximately 540 patients had received lot number of 066H21A in past and had an its 30 days of an expiry date. The vaccine was administered up until its manufactured expiry date of 04-Apr-2022 and this lot number was no longer possessed. No treatment medications were reported.   This case was linked to MOD-2022-542869 (Patient Link).
Patient was given a Men Bexaro instead of the intended/ordered vaccine of menquadfi.
Oval , peanut size ball on left arm. Fever, headache , body ache , and weakness, and constipated  . Had to get surgery to remove the oval ball from arm .
Pt recieved 2nd covid vaccination from Moderna.  Her 1st vaccine was Pfizer.    Counseled pt to not repeat any doses of Covid vaccine.  No adverse reactions noted.
Ringing in ears, loss of sight and hearing, pallor, blue lips, unable to move or speak, EMS called.
Arm red, warm, swollen, bruise, hard to move arm on 8/30/17, came to pharmacy on 9/2 , swelling reduced, patient can move arm, getting better per patient, told to watch, if not better in couple of days go to doctor.
Rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.  Treatment information was not provided.
CHILD'S DATE OF BIRTH WRITTEN  ON CONSENT SIGNED BY INDIVIDUAL IDENTIFYING AS FATHER. CHILD IDENTIFIED IN (#149264420) WITH DATE OF BIRTH. CHILD TOO YOUNG FOR VACCINE.
This spontaneous report was received from a certified medical assistant (healthcare worker) refers to a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 27-JAN-2016, the patient was vaccinated with an improperly stored Oral, ROTATEQ lot # L027719, 28-APR-2017. This is one of the several reports received from the same reporter. Additional information has been requested.
Within 4 hours of vaccination, I started experiencing loss of taste and smell. 6 hours after vaccination, there was total loss of taste and smell with associated congestion, cough and fatigue. 3 days after vaccination, my cough has gotten worse, with associated sore throat and still no taste or smell.
A consumer report has been received. The report concerns a, male consumer, who had been receiving FLUMIST, 0.2 millilitres, yearly. FLUMIST started during Oct-2015. The patient experienced not feeling well and dizziness which started during Oct-2015. The patient recovered from the event of not feeling well and dizziness on an unspecified date. The report was considered to be non-serious.
September 3, 2020 feverbetween 100.2 and 100.8 for approximately 12 hours. Redness of injection site for one week.  Sept. 3, 2020, mid afernoon, one brief dizzy spell and wave of nausea.  No vomiting.
Patient is 86y.o. female who was admitted to the hospital with AKI on CKD. Medical problems treated during this admission are detailed below: Acute kidney injury on CKD stage 5 - Likely prerenal due to poor PO intake. Continues to make urine. Baseline Cr around 4, Cr 5.08 on admission, with improvement with IVF. Cr stable after stopping IVF. PO intake improved. Recommendations - Outpt follow-up with nephrology  - Stop spironolactone - Continue home calcitriol, sodium bicarbonate  COVID-19 infection - Vaccinated x3, but overdue for second booster. On room air throughout admission. Procalcitonin minimally elevated but no evidence of pneumonia on CXR. ID consulted and no specific treatment recommended for COVID  given renal insufficiency and no oxygen need.   Mild hyponatremia - Suspect due to poor PO intake. Resolved.   Chest pain - Resolved. Troponin trend flat. CXR without acute process.  Essential hypertension - Stop spironolactone. Resume amlodipine. Continue other home medications.   Evaluation on Day of Discharge: Condition on discharge - Improved No acute events overnight. This morning, reports mild nausea but was able to eat yesterday. No other new complaints, eager for discharge home.
Possible seizure. Patient suddenly lost the ability to stand and the majority of muscle control. She would get onto her knees and immediately fall backwards. Blank look on her face. After several falls, she laid in the floor trembling. I picked her up and hot her to nurse and she was fine after eating, just a bit fatigued. Entire episode lasted 3-5 minutes. Called 24 hour nurse line and was told to watch her for 2 hours and if symptoms presented again I should take her to the ER.
Subsequently after having the vaccines on the 7/2, developed symptoms of left sided facial droop, hemiparalysis, decreased sensation to his left face, slurred speech and difficulty chewing. Symptoms and physical exam most suggestive of Bell's (facial nerve) palsy.
A short time after leaving the health center, the pt became ill, complained of nausea with a headache. She complained of a sever headache all night, experienced nausea and vomiting, called ER in the night was told to give Tylenol. Mother called the health center to report symptoms.
Small bite size whelps began popping up on neck, hand, hip, backs of legs. Extremely itchy, within hours it had spread to thighs and shoulders. 2 Benadryl would not relieve the itching. Woke up and it had further spread down legs, on ribs, wrist, arm pit. The whelps have also grown in size. Started to feel very faint and nauseous, become very cold but also started to sweat.
I had moderate to severe symptoms that came on the next morning after the shot. I had a temp of 100.4, pretty severe body and joint aches, moderate fatigue, headache and then chills/sweats. The fever broke that night and I'm feeling better, but not 100% today. The reason I am filling this out is that 3 other neighbors also had the same, if not more, severe reactions and all had the same Lot#ER8736. Other neighbors that went to the same clinic and had the normal, milder reactions all had a different lot number. I am not concerned about efficacy or anything else as much as sharing this data point with this group and anyone else in case it is relevant.
4 days after booster vaccine developed severe joint pain and occassional chills.  Joint pain increasingly worse for past 3 weeks.  Pain is most severe in hands elbows shoulders knees but travels all over the body randomly.  Prior moderate pain in thumbs but never had these symptoms before.  On prednisone.  Debilitating pain off prednisone.  Lyme disease and RA disease testing is negative.  Next steps with doctor pending.  Pain causing inability to work.  Hands and wrist pain don?t allow for basic keyboard use at computer.
pt had high pitched scream & could not be comforted from 5PM to 11PM; screamed when touched or picked up; cried on & off from 11PM to 8AM; very lethargic all day; t101; scream as non-stop & very high pitched;
Onset of urticarial rash on trunk and LUE.  Had resolved by 10-30-2009.
A nurse reported that a male received an injection of TD Toxoids and subsequently developed an injection site reaction characterized by redness and soreness. He recovered.
Complaint of bad headache 1 hour after administration.  Feeling hot and cold, labored breathing, facial redness, site of injection ok, notified via phone call at 5:40,  Benadryl and Aleve taken temperature 100, facial swelling, to emergency room 05/18, 8PM.
Information has been received from a registered nurse concerning a 4 year old male who on 09/04/1997 was vaccinated with varicella vaccine SC in the left thigh. On 04/20/2001, the pt experienced 20-25 itchy, vesicular lesions across his body. He had a few on his neck, arms and legs. Some of the lesions were small with a vesicular appearance. He had no fever, he was seen at the pediatrician's office on 04/24/2001. Subsequently, he recovered. Additional info is not expected.
passed away shortly after receiving the Pfizer vaccine, sudden heart attack; heart ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 95-year-old female patient received BNT162b2 (BNT162B2), on 06Apr2021 as dose 2, single (Lot number: EN6206, Expiration Date: Jun2021) at the age of 94 years for covid-19 immunisation in the pharmacy out of a grocery store lane. The patient's relevant medical history included: "Diabetic" (unspecified if ongoing), note: the patient was taking very low dose of a Diabetic medication. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1, lot number unknown), administration date: 19Mar2021, when the patient was 94-year-old, for COVID-19 immunisation. The following information was reported: MYOCARDIAL INFARCTION (death, hospitalization, medically significant), outcome "fatal", described as "passed away shortly after receiving the Pfizer vaccine, sudden heart attack"; ANGINA PECTORIS (death, hospitalization, medically significant), outcome "fatal", described as "heart ache". The patient was hospitalized for myocardial infarction, angina pectoris (start date: 06Apr2021). The events "passed away shortly after receiving the Pfizer vaccine, sudden heart attack" and "heart ache" required emergency room visit. Therapeutic measures were taken as a result of myocardial infarction, angina pectoris. The patient date of death was unknown. Reported cause of death: "passed away shortly after receiving the Pfizer vaccine, sudden heart attack", "heart ache". It was not reported if an autopsy was performed. Clinical course: The reporter stated it was the day after this shot(2nd dose) patient started complaining about the heart ache and that was on to the last days she lived. The reporter took patient to the emergency room in hospital on the same day she had a 2nd dose on 06Apr2021. The patient was in emergency room, the reporter didn't know what they were doing for patient. She came and shortly after she passed away, she was not taking anything else, they just did the heart surgery for her. Reporter stated, the patient experienced heart ache and then ended up with sudden heart attack. The patient passed away shortly after receiving the Pfizer vaccine, sudden heart attack. It was reported the patient was dead like about 8-9 months now.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200584288 same patient, different dose and event; Reported Cause(s) of Death: heart ache; passed away shortly after receiving the Pfizer vaccine, sudden heart attack
From telephone contact on 08/10/01 with reporter, it was stated that a  4 month old patient was administered Tripedia Lot #  UO311DA, ActHIB, lot # UA606AA and IPOL lot # T08412 in 08/06/01. On 08/07/01, the patient experienced a local reaction of redness and swelling at the Tripedia injection site. Treated symptomaticly by physician, the reaction resolved.
Information has been received from a pharmacist concerning a female nurse who was vaccinated with PNEUMOVAX 23 (Lot number 0980X). The pharmacist reported that the patient developed itching; redness and soreness at the injections site. It is not known if this was the first dose of PNEUMOVAX 23 or not. The patient recovered on an unspecified date. The patient sought medical attention contacting the pharmacist. Follow-up information was received from the pharmacist indicating that the patient was a 71 year old caucasian patient, weighing 169 pounds and 68 inches in height, who on 18-Mar-2009 at 8:23 AM was vaccinated intramuscularly with the first dose of PNEUMOVAX 23. There were no illnesses at the time of the vaccination. There was no concomitant medication. The pharmacist reported that on 18-Mar-2009 at 8:23 AM the patient developed an area very red itchy; sore and warm to touch; and small blister. It was reported that the patient took BENADRYL, Over the counter and was told to elevate and rest arm per doctor. At the time of the report, the patients status was unknown. This is one of several reports from the same source. No further information is available.
Child twitched and lost consciousness for a few seconds - thought to be a faint episode while seated on exam table. Pt. was monitored - given water, and a sucker. Rested. Discharged in good condition.
Swelling (golfball to ping-pong ball size), itching, dolor, rubor, erythema(3-3 1/2 inches in diameter) appeared about hours post injection. Not treated. Symptoms are improving.